Empowering Small Molecule Drug Discovery by Automatic DEL Screening
In this webinar, our expert speakers showcase our automatic DNA-encoded library (DEL) screening device, DELman.
DNA-encoded library technology has proven to be a powerful tool for drug discovery. There are now several DEL-derived candidates in clinical stage. DEL enables researchers to explore vast chemical space with millions to billions of compounds. With DELman and other self-service data analysis tools, we show how researchers can wield DEL screens in appointed scenarios to obtain stable and reliable screening outcomes.
Related Content
DNA-encoded library (DEL) technology has been recognized as a major screening method with unique advantages for offering vast chemical diversity...
VIEW RESOURCEChemical inducers of proximity (CIPs) are small molecules that induce the proximity of two biological targets, usually proteins. Molecular glues...
VIEW RESOURCE